Cargando…
Myocardial Regeneration via Progenitor Cell-Derived Exosomes
In the past 20 years, a variety of cell products has been evaluated in terms of their capacity to treat patients with acute myocardial infarction and chronic heart failure. Despite initial enthusiasm, therapeutic efficacy has overall been disappointing, and clinical application is costly and complex...
Autores principales: | Maring, Janita A., Beez, Christien M., Falk, Volkmar, Seifert, Martina, Stamm, Christof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733225/ https://www.ncbi.nlm.nih.gov/pubmed/29333167 http://dx.doi.org/10.1155/2017/7849851 |
Ejemplares similares
-
Towards a Novel Patch Material for Cardiac Applications: Tissue-Specific Extracellular Matrix Introduces Essential Key Features to Decellularized Amniotic Membrane
por: Becker, Matthias, et al.
Publicado: (2018) -
Cardiomyocyte precursors generated by direct reprogramming and molecular beacon selection attenuate ventricular remodeling after experimental myocardial infarction
por: Bachamanda Somesh, Dipthi, et al.
Publicado: (2023) -
Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease
por: Nazari‐Shafti, Timo Z., et al.
Publicado: (2020) -
Stem cell-derived exosomes - an emerging tool for myocardial regeneration
por: Lazar, Erzsebet, et al.
Publicado: (2018) -
Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes
por: Beez, Christien M., et al.
Publicado: (2019)